Treatment of wounds in the neuropathic form of diabetic foot syndrome using platelet-rich autoplasma: problems and prospects

Introduction. The neuropathic form of diabetic foot syndrome develops as a result of hyperglycemia and neuropathy, which further leads to a violation of reparative processes.

The standard amount of therapy, including surgical treatment of the wound, systemic antibacterial therapy, and limb unloading, is often insufficient to stimulate healing.

Platelet–rich autoplasma (PRP) containing growth factors is a promising treatment method that accelerates tissue repair. This review examines the effectiveness of PRP in stimulating the healing of chronic wounds, including wounds with neuropathic form of diabetic foot syndrome.

The purpose of this study is to review the available literature from domestic and foreign authors and to systematize the data on the mechanism of action, clinical efficacy, and optimal protocols for using platelet–rich autoplasma in the treatment of wounds in NFSDS.

Materials and methods. Analysis of available literary data of foreign and domestic authors, scientific databases e–library, PubMed, PMC.

Results. The analysis of literature data proved the role of PRP in accelerating wound healing in neuropathic form of diabetic foot syndrome by stimulating angiogenesis, collagen synthesis, and reducing the risk of amputations and infection recurrence. The technique does not replace the standard treatment, but increases its effectiveness.

Conclusion. The use of platelet–rich autoplasma makes it possible to increase the effectiveness of treatment of chronic wounds, including wounds with neuropathic form of diabetic foot syndrome by activating reparative processes. This method can be considered as a component of personalized therapy.

1. Hamm R. L. Wounds. Diagnosis and treatment: atlas–handbook. Translated from English by V.A. Mitish, Y.S. Paskhalova. M. : GEOTAR– Media. 2021, 536 p. (In Russ.)

2. Obolensky V.N. Modern methods of treating chronic wounds. MS, 2016, no 10. (In Russ.)

3. Zhunisov B., Bakytzhan A. Review of modern methods for treating long–standing non–healing wounds. Eurasian Journal of Medical and Natural Sciences, 2025, no 5 (10), pp. 153–159. (In Russ.)

4. Komelyagina E.Y., Antsiferov M.B. Diabetic foot syndrome: pathogenesis, diagnosis, contemporary approaches to therapy. The Treating Physician, 2025, no 3 (28), pp. 9–15. (In Russ.)

5. Bogdanov S.B., Karakulov A.V. Improving the integrated use of cellular therapy and biological wound coverings in the treatment of patients with skin defects. Plastic Surgery and Aesthetic Medicine, 2019, no 4, pp. 43–49. (In Russ.)

6. Krupina E.A. Molecular and biological aspects of PRP and ACP– therapy: analysis. Bulletin of the National Medical and Surgical Center named after N. I. Pirogov, 2020, volume 15, no 3, part 2. (In Russ.)

7. Yerashov P.A., Denisenko V.L. Platelet–rich plasma (PRP). Its classification, preparation, and use in modern medicine (review). Bulletin of VGMU, 2022, no 6. (In Russ.)

8. Kaprin A.D., Kostin A.A. Autoplazma enriched with platelet growth factors in the treatment of erectile dysfunction: review of preclinical and clinical studies. Research'n Practical Medicine Journal, 2019, no 3. (In Russ.)

9. Vasilyeva E.F., Brusov O.S. Platelets, hemostasis and mental disorders. S.S. Korsakoff Neuroscience and Psychiatry Journal, 2019, no 119 (11), pp. 103–108. (In Russ.)

10. Makarov M.S., Borovkova N.V. Pathophysiological features of platelets in sepsis. Far Eastern Medical Journal, 2023, no 1. (In Russ.)

11. Krivoshchekov E.P., Alyapyshev G.S. Use of bioplastic, cellular and biological materials for healing wound defects. Sciences of Europe, 2019. (In Russ.)

12. Malygina M.A., Borovkova N.V. Use of platelet–rich plasma in diseases and injuries of the musculoskeletal system. Transplantology, 2017, no 4. (In Russ.)

13. Achkasov E.E., Bezuglov E.N. Use of autoplazma rich with platelets in clinical practice. Biomedicina, 2013, no 4, pp. 46–59. (In Russ.)

14. Borovkova N.V., Filatova I.A. Efficacy of using platelet–rich plasma lysate (PRP Lyse) in patients with corneal erosions or post–traumatic eyelid tissue scarring. Russian Ophthalmologic Journal, 2020, no 13 (3), pp. 8–14. (In Russ.)

15. Kachalov S.N., Lastovka A.S. Characteristics of properties of first– and second–generation platelet concentrates. Modern Dentistry, 2024, no 1 (92). (In Russ.)

16. Minaev S.V., Timofeev S.I. Platelet–rich plasma in surgical practice. A literature review. Russian Journal of Pediatric Surgery, Anesthesiology and Reanimatology, 2023, no 3. (In Russ.)

17. Tang H. Platelet–rich plasma for the treatment of diabetic foot ulcers: a systematic review. Frontiers in Endocrinology, 2023, volume 14.

18. Komelyagina E.Y., Antsiferov M.B. Growth factors in therapy of ulcers in diabetic foot syndrome. Diabetes, 2019, no 4. (In Russ.)

19. Abdrakhmanova S., Imashpaev D. Experience of using allogeneic plasma enriched with soluble platelet factors in the treatment of diabetic foot syndrome. Eurasian Journal of Applied Biotechnology, 2024. (In Russ.)

20. OuYang H., Tang Y., et al. Platelet–rich plasma for the treatment of diabetic foot ulcer: a systematic review. Frontiers in Endocrinology (Lausanne), 2023.

21. OuYang H., Yang J., et al. Effects of different treatment measures on the efficacy of diabetic foot ulcers: a network meta–analysis. Frontiers in Endocrinology (Lausanne), 2024.

22. Gomez P.T., Andrews K.L., et al. Platelet–Rich Plasma in the Treatment of Diabetic Foot Ulcers. Advances in Skin & Wound Care, 2024, pp. 608–615.

23. Yasser O. et al. Autologous platelet–rich plasma vs conventional dressing in the management of chronic diabetic foot ulcers. Wounds: A Compendium of Clinical Research and Practice, 2022.

24. Panin S.I., Mozgovoy P.V. Results of using platelet–rich plasma in surgical practice (evidence base review). Vestnik VolGMU, 2025, no 1. (In Russ.)

25. Obolenskiy V.N., Ermolova D.A., et al. Clinical and economic effectiveness of the use of platelet–rich plasma in the treatment of chronic wounds. Wound Medicine, 2017, no 19, pp. 27–32. (In Russ.)

26. Hirase T., Ruff E., et al. Topical application of platelet–rich plasma for diabetic foot ulcers: A systematic review. World Journal of Diabetes, 2018, no 9 (10), pp. 172–179.

27. Korovin A.Y., Popandopulo K.I., et al. Comprehensive treatment of trophic ulcers of the lower limbs in patients with type 2 diabetes. Surgery. Journal named after N. I. Pirogov, 2022, no 4, pp. 48–53. (In Russ.)

28. Xu H., Huang K., et al. Efficacy and safety of platelet–rich plasma versus conventional care in diabetic foot ulcers: a meta–analysis of randomized controlled trials. Acta Diabetologica, 2025, no 62 (10), pp. 1585–1596.